Page last updated: 2024-09-05

solifenacin succinate and Hakim Syndrome

solifenacin succinate has been researched along with Hakim Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, KS; Chung, JH; Ha, US; Ham, WS; Han, JH; Kang, DH; Lee, JY; Lee, SH; Lee, SW; Park, J; Yoo, TK	1

Trials

1 trial(s) available for solifenacin succinate and Hakim Syndrome

Article	Year
Efficacy and safety of solifenacin to treat overactive bladder symptoms in patients with idiopathic normal pressure hydrocephalus: an open-label, multicenter, prospective study. Neurourology and urodynamics, 2012, Volume: 31, Issue:7 Topics: Adult; Female; Humans; Hydrocephalus, Normal Pressure; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quality of Life; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics; Ventriculoperitoneal Shunt	2012

Article

Year

Efficacy and safety of solifenacin to treat overactive bladder symptoms in patients with idiopathic normal pressure hydrocephalus: an open-label, multicenter, prospective study.

Neurourology and urodynamics, 2012, Volume: 31, Issue:7

Topics: Adult; Female; Humans; Hydrocephalus, Normal Pressure; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quality of Life; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics; Ventriculoperitoneal Shunt

2012